美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PGIM Corporate Bond 10+ Year ETF

50.60

0.0000

成交量：1.00

成交额：50.35

市值：7,590.45万

市盈率：- -

高：50.60

开：50.60

低：50.60

收：50.60

52周最高：50.78

52周最低：50.22

股本：150.00万

流通股本：150.00万

量比：0.09

换手率：0.00%

股息：- -

股息率：- -

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻

【干货】医美注射材料产业链全景梳理及区域热力地图

前瞻产业研究院

科济药业发布2025中期业绩

新消费派 | “颜值经济新势力”博弈加剧，童颜针和少女针市场走向何方？

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PCL"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PCL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCL\",,,,,undefined,":{"symbol":"PCL","market":"US","secType":"STK","nameCN":"PGIM Corporate Bond 10+ Year ETF","latestPrice":50.603,"timestamp":1756224931258,"preClose":50.603,"halted":0,"volume":1,"delay":0,"floatShares":1500000,"shares":1500000,"eps":0,"marketStatus":"交易中","change":0,"latestTime":"08-26 14:52:48 EDT","open":50.603,"high":50.603,"low":50.603,"amount":50.345,"amplitude":0,"askPrice":50.44,"askSize":100,"bidPrice":50.35,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1756238400000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":50.603,"sharesOutstanding":1500000,"nav":50.507,"aum":75760706.18,"bidAskSpread":0,"volumeRatio":0.087494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PCL\",,,,,undefined,":{"symbol":"PCL","floatShares":1500000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.087494,"shares":1500000,"dividePrice":0,"high":50.603,"amplitude":0,"preClose":50.603,"low":50.603,"week52Low":50.22,"pbRate":"--","week52High":50.7813,"institutionHeld":0.7878,"latestPrice":50.603,"eps":0,"divideRate":0,"volume":1,"delay":0,"ttmEps":0,"open":50.603,"prevYearClose":50.22,"prevWeekClose":50.376,"prevMonthClose":50.22,"prevQuarterClose":50.22,"fiveDayClose":50.2222},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PCL\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PCL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PCL\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PCL\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2561231751","title":"【干货】医美注射材料产业链全景梳理及区域热力地图","url":"https://stock-news.laohu8.com/highlight/detail?id=2561231751","media":"前瞻产业研究院","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561231751?lang=zh_cn&edition=fundamental","pubTime":"2025-08-23 13:00","pubTimestamp":1755925258,"startTime":"0","endTime":"0","summary":"医美注射材料产业链区域热力地图：山东分布最集中我国医美注射材料产业链上的企业主要集中在山东省地区，其次是在广东省、江苏省、上海市、浙江省以及北京市等地区。从我国医美注射材料产业链企业区域分布来看，山东省医美注射材料产业链企业数量较多，原材料生产企业包括华熙生物、福瑞达、阜丰集团等;器械制造企业包括威高股份等;产品研发与制造企业包括华熙生物等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250823130532975a97fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250823130532975a97fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCL"],"gpt_icon":0},{"id":"2559465749","title":"科济药业发布2025中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2559465749","media":"美通社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559465749?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 08:15","pubTimestamp":1755216900,"startTime":"0","endTime":"0","summary":"上海2025年8月15日 /美通社/ -- 科济药业，一家专注于开发创新CAR-T细胞疗法的生物制药公司，已发布2025中期业绩。截至2025年6月30日止六个月，科济药业的毛利约为人民币2,900万元。科济药业与华东医药已就在中国大陆地区商业化赛恺泽签订合作协议。于2025年上半年，赛恺泽完成认证及备案的医疗机构覆盖全国20多个省市，科济药业共计从华东医药获得111份有效订单。本次增资完成后，科济药业于优恺泽的股份将由100%稀释至92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4751567_ZH51567_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK1587","CAR","OS","BK1585","BK4211","PCL","BK4017","BK1574","BK1161","LU1223082519.USD","BK4230","02171","LU1223082196.USD","BK4077","SLE","BK4022","BK4195","CDE","LU1223083913.SGD","PFS","BK4097"],"gpt_icon":0},{"id":"2558784654","title":"新消费派 | “颜值经济新势力”博弈加剧，童颜针和少女针市场走向何方？","url":"https://stock-news.laohu8.com/highlight/detail?id=2558784654","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558784654?lang=zh_cn&edition=fundamental","pubTime":"2025-08-11 18:21","pubTimestamp":1754907718,"startTime":"0","endTime":"0","summary":"新华财经上海8月11日电（谷青竹）医美再生注射产品赛道（童颜针和少女针）持续升温，仅7月便动作频频：7月10日，国家药品监督管理局官网公布两款童颜针获批，分别是引进的韩国产品爱唯缇和西宏医药的丽真然。7月19日，四环药业也推出了童颜针和少女针两类共三款再生类注射新品。7月31日，普丽妍宣布完成近5000万美元的C轮融资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202508113481488219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4563","BK4077","PCL","BK4503","SY"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/PCL\",params:#limit:6,delay:false,,,undefined,":[]}}